Utilization of Indocyanine Green for Augmentation of Pulmonary Metastases Resection in Pediatric, Adolescent, and Young Adult Sarcoma Patients
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jan 2026 · 1 min read
In brief
In brief
This study evaluates ICG fluorescence imaging during lung metastasis resection in 31 young sarcoma patients, demonstrating 81% sensitivity and identifying 17% of lesions missed by standard visualization. The technique proved safe and effective for improving surgical completeness, though sensitivity decreased in previously irradiated lungs.
Written by the GCMD Library team from the article.
Statements in this article
Complete pulmonary metastasectomy is central to curative-intent therapy for sarcoma.
Indocyanine green was administered at a dose of 4 mg/kg, 24 hours before surgery.
Overall sensitivity of ICG for detecting metastatic lesions was 81.0% with a positive predictive value of 39.0%.
ICG identified 17.0% of metastases not palpable or visible on inspection.
Patients with prior lung radiation demonstrated lower sensitivity at 64.0% than the overall cohort.
No adverse reactions to ICG were observed.
ICG fluorescence imaging is a safe adjunct to pulmonary metastasectomy in pediatric, adolescent, and young adult sarcoma patients.